Health and Medicine

News about UB’s health sciences programs and related community outreach. (see all topics)

  • UB Researchers Use Virtual Reality to Treat Car-Accident Survivors Suffering from Post-Traumatic Stress
    10/30/03
    Researchers from the University at Buffalo have developed a virtual-reality driving simulator that may help car-accident survivors recover from post-traumatic stress disorder (PTSD) -- a prevalent, but commonly untreated, condition associated with serious car accidents.
  • Transcendent Courage and Endurance Are Subjects of "The Will To Live," a New Film to be Introduced at UB
    10/30/03
    A new documentary by Danish director and filmmaker Anne-Gyrithe Bonne, "The Will to Live: A Notebook on Love, Hate and Reconciliation," will be presented, along with one of its subjects, Cambodian-American writer Chanrithy Him, on Nov. 20 at the University at Buffalo.
  • Four UB Faculty Members Honored by SUNY
    10/28/03
    Four University at Buffalo faculty members recently were honored by the State University of New York for significant accomplishments in their respective academic fields.
  • UB Researchers Show First Evidence of Pharmacogenomic Differences in Patients' Responses to Widely Used MS Drug
    10/28/03
    University at Buffalo researchers using the latest computer-assisted technologies of genetic analysis have shown for the first time how a widely used drug for treating multiple sclerosis -- interferon beta (IFN-beta-1a) -- can modulate the expression of particular genes in patients being treated for the disease.
  • Potential to Help High-Risk Children and Families Focus of Study
    10/27/03
    Researchers at the University at Buffalo's Research Institute on Addictions are developing a hybrid treatment method that incorporates training for parents, couples therapy and reduction of substance abuse as a means to improve the behavior and functioning of children of substance-abusing parents.
  • From Lab Bench to Boardroom: UB Chemist's Powerful Approach to Anti-Cancer Compounds Makes the Leap
    10/27/03
    In a classic example of scientific research that has successfully outgrown the university lab where it was born, a University at Buffalo professor's unique method for designing and synthesizing anti-cancer compounds, called protein kinase inhibitors, is being commercialized.
  • Collaboration Between UB Institute and Amsterdam Experts to Test Drug Treatment Model Originated in Buffalo
    10/27/03
    A joint project between the University at Buffalo's Research Institute on Addictions and the Jellinek Clinic in Amsterdam, the Netherlands, will examine how behavioral couples therapy works for cocaine-abusing patients across cultures.
  • Using GIS, Simulation of Flu-Like Illnesses Like SARS Draws a Nuanced Picture of Public Health Threats
    10/24/03
    A new, computational method for simulating the spread of flu-like illnesses like SARS (severe acute respiratory syndrome) that is being developed by a University at Buffalo geographer may provide policymakers and analysts with new ammunition for studying and predicting the pattern of public-health threats in urban communities.
  • Genco Receives Ross Award from American Dental Association
    10/24/03
    Robert J. Genco, D.D.S., Ph.D., of Buffalo, SUNY Distinguished Professor in the Department of Oral Biology in the University at Buffalo School of Dental Medicine, has won the 2003 Norton M. Ross Award for Excellence in Clinical Research from the American Dental Association for his research into the relationship between periodontal and cardiovascular diseases.
  • UB and UR Technologies Being Licensed By Company for Product That Will Put Prescriptions on Digital Paper
    10/21/03
    Illegible prescriptions scrawled on physicians' notepads could become a thing of the past, thanks to two complementary technologies developed at the University at Buffalo and the University of Rochester that together are being licensed by mobileLexis, a digital paper solutions company based in Salt Lake City, Utah.